Neos Therapeutics to Present at the Wells Fargo Healthcare Conference
August 29, 2018 07:30 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a fully integrated pharmaceutical company focused on developing, manufacturing and...
New Drug Application Submitted in Japan for INTUNIV® (guanfacine hydrochloride extended release) in Adults with ADHD
August 13, 2018 02:00 ET
|
Shire plc
New Drug Application Submitted in Japan for INTUNIV® (guanfacine hydrochloride extended release) in Adults with ADHD Shire’s partner, Shionogi, filed application to expand INTUNIV® indication in...
Neos Therapeutics Reports Second Quarter 2018 Financial Results
August 08, 2018 07:00 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Praxis Bioresearch Awarded $1.5 Million Fast-Track SBIR Grant for Development of Novel Prodrug Stimulant with Abuse-Deterrent Properties
August 07, 2018 08:05 ET
|
Praxis Bioresearch
MENLO PARK, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Praxis Bioresearch, a biopharmaceutical company focused on the discovery and development of novel therapeutics for chronic neuropsychiatric and...
Neos Therapeutics to Host Second Quarter 2018 Financial Results Conference Call on August 8, 2018
August 01, 2018 07:30 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
RespireRx Pharmaceuticals Inc. Announces Publication of Ampakine Data:
July 25, 2018 09:00 ET
|
RespireRX Pharmaceuticals Inc.
Effects of Chronic Systemic Low-impact Ampakine Treatment on Neurotrophin Expression in Rat Brain Glen Rock, N.J., July 25, 2018 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI)...
Neos Therapeutics Appoints Jerry McLaughlin as Chief Executive Officer
June 27, 2018 16:30 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, June 27, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
RespireRx Pharmaceuticals Inc. Announces Resignation of Dr. James S. Manuso
June 19, 2018 16:14 ET
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J, June 19, 2018 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. announces the decision of Dr. James S. Manuso to resign as president, CEO, Vice Chairman and member of the Board of...
SAP Teams with Cognoa to Bridge Gap in Healthcare for Employees Raising Young Children
June 12, 2018 09:03 ET
|
Cognoa
PALO ALTO, Calif., June 12, 2018 (GLOBE NEWSWIRE) -- Cognoa, a digital behavioral health company, today announces its partnership with SAP, a market leader in enterprise application software. More...
Neos Therapeutics to Participate in Two June Conferences
May 31, 2018 16:05 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, May 31, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...